Invasive fungal infections in children with hematologic and malignant diseases

Journal of Pediatric Hematology/Oncology

Volumn 37, Issue 2, 2015, Pages e69-e72

  Ozsevik, Sevinc N ^a   Sensoy, Gulnar ^a   Karli, Arzu ^a   Albayrak, Canan ^a   Dagdemir, Ayhan ^a   Belet, Nursen ^a   Elli, Murat ^a   Fisgin, Tunc ^a   Ozyurek, Emel ^a   Duru, Feride ^a   Albayrak, Davut ^a  

^a ONDOKUZ MAYIS UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

cancer; invasive fungal infection; pediatric patients

Indexed keywords

C REACTIVE PROTEIN; CASPOFUNGIN; STEROID; VORICONAZOLE; ANTIFUNGAL AGENT;

ADULT; ARTICLE; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; BONE MARROW TRANSPLANTATION; BRAIN ABSCESS; CANDIDA PARAPSILOSIS; CAUSE OF DEATH; CENTRAL NERVOUS SYSTEM INFECTION; CENTRAL VENOUS CATHETER; CHILD; CONTROLLED STUDY; DISEASE DURATION; FEMALE; FEVER; HEMATOLOGIC DISEASE; HUMAN; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MORTALITY; NEUTROPENIA; NEUTROPHIL COUNT; NOSE INFECTION; PICHIA KUDRIAVZEVII; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; SINONASAL INFECTION; SKIN INFECTION; SYSTEMIC MYCOSIS; TOTAL PARENTERAL NUTRITION; TREATMENT DURATION; ADOLESCENT; COMPLICATION; FOLLOW UP; FUNGEMIA; INFANT; MYCOSES; TREATMENT OUTCOME; VIROLOGY;

ADOLESCENT; ANTIFUNGAL AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; FUNGEMIA; HEMATOLOGIC NEOPLASMS; HUMANS; INFANT; MALE; MYCOSES; TREATMENT OUTCOME;

EID: 84924273946     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0000000000000225     Document Type: Article

References (21)

1. Mor M, Gilad G, Kornreich L, et al. Invasive fungal infections in pediatric oncology. Pediatr Blood Cancer. 2011;56: 1092-1097.
2. Villarroel M, Aviles CL, Silva P, et al. Risk factors associated with invasive fungal disease in children with cancer and febrile neutropenia: a prospective multicenter evaluation. Pediatr Infect Dis J. 2010;29:816-821.
3. Sipsas NV, Kontoyiannis DP. Invasive fungal infections in patients with cancer in the Intensive Care Unit. Int J Antimicrob Agents. 2012;39:464-471.
4. Roilides E. Invasive candidiasis in neonates and children. Early Hum Dev. 2011;87(suppl 1):S75-S76.
5. Brissaud O, Guichoux J, Harambat J, et al. Invasive fungal disease in PICU: epidemiology and risk factors. Ann Intensive Care. 2012;2:6.
6. De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis. 2008;46:1813-1821.
7. Palazzi DL. The use of antimicrobial agents in children with fever during chemotherapy-induced neutropenia. The importance of risk stratification. Pediatr Infect Dis J. 2011;30: 887-890.
8. Pappas PG, Kauffman CA, Andes D, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;48:503-535.
9. Walsh TJ, Anaissie EJ, Denning DW, et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis. 2008;46:327-360.
10. Kobayashi R, Kaneda M, Sato T, et al. The clinical feature of invasive fungal infection in pediatric patients with hematologic and malignant diseases: a 10-year analysis at a single institution at Japan. J Pediatr Hematol Oncol. 2008;30: 886-890.
11. Rosen GP, Nielsen K, Glenn S, et al. Invasive fungal infections in pediatric oncology patients: 11-year experience at a single institution. J Pediatr Hematol Oncol. 2005;27:135-140.
12. Ostrosky-Zeichner L. Invasive mycoses: diagnostic challenges. Am J Med. 2012;125(suppl):S14-S24.
13. Dornbusch HJ, Manzoni P, Roilides E, et al. Invasive fungal infections in children. Pediatr Infect Dis J. 2009;28:734-737.
14. Castagnola E, Cesaro S, Giacchino M, et al. Fungal infections in children with cancer: a prospective, multicenter surveillance study. Pediatr Infect Dis J. 2006;25:634-639.
15. Saghrouni F, Ben Youssef Y, Gheith S, et al. Twenty-nine cases of invasive aspergillosis in neutropenic patients. Med Mal Infect. 2011;41:657-662.
16. Steinbach WJ. Epidemiology of invasive fungal infections in neonates and children. Clin Microbiol Infect. 2010;16: 1321-1327.
17. Steinbach WJ. Pediatric aspergillosis: disease and treatment differences in children. Pediatr Infect Dis J. 2005;24:358-364.
18. Kim MJ, Lee KS, Kim J, et al. Crescent sign in invasive pulmonary aspergillosis: frequency and related CT and clinical factors. J Comput Assist Tomogr. 2001;25:305-310.
19. Burgos A, Zaoutis TE, Dvorak CC, et al. Pediatric invasive aspergillosis: a multicenter retrospective analysis of 139 contemporary cases. Pediatrics. 2008;121:1286-1294.
20. Choi SH, Kang ES, Eo H, et al. Aspergillus galactomannan antigen assay and invasive aspergillosis in pediatric cancer patients and hematopoietic stem cell transplant recipients. Pediatr Blood Cancer. 2013;60:316-322.
21. Zaoutis TE, Greves HM, Lautenbach E, et al. Risk factors for disseminated candidiasis in children with candidemia. Pediatr Infect Dis J. 2004;23:635-641.